Viltis

Viltis

Biotechnology Research

San Diego, California 4,697 followers

Delivering expert consulting services to pharmaceutical, biotechnology, medical device, and diagnostics companies

About us

As Viltis, we are a consultancy dedicated to crafting personalized resource solutions exclusively for pharmaceutical, biotechnology, medical device, and diagnostics companies. Our core mission is to provide expert solutions to organizations grappling with resource challenges, all while making a meaningful impact on the lives of our consultants. Over the years, our consultants, operating under the Viltis banner, have consistently delivered innovative solutions to some of the industry's largest and most renowned enterprises.

Website
http://www.viltis.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
San Diego, California
Type
Privately Held
Founded
2020
Specialties
Life Sciences, Consulting, Recruiting, Scientific, Quality, Engineering, Clinical, Regulatory, Biologics, Medical Device, Pharmaceutical, and IVD

Locations

Employees at Viltis

Updates

  • View organization page for Viltis, graphic

    4,697 followers

    🚀 Innovation in Transplant Medicine: Paragonix Launches Pancreas Transplant Transport System Exciting news in the medtech world! Paragonix Technologies has just launched a groundbreaking transport system for pancreas transplants. This cutting-edge technology is set to revolutionize the way donor organs are preserved and transported, significantly improving transplant outcomes. 🌟 Highlights: Advanced Preservation: The new system ensures optimal conditions for the pancreas during transport, maintaining its viability for longer periods. Enhanced Safety: Designed to reduce the risk of damage and contamination, the system offers a more reliable method for transporting this vital organ. Improved Outcomes: By preserving the pancreas in better condition, this innovation aims to increase the success rates of transplant surgeries and enhance patient recovery. 🧬 Implications for Healthcare: The launch of this transport system represents a major step forward in transplant medicine. As we continue to push the boundaries of what's possible in biotech and medtech, innovations like this are crucial for saving lives and improving patient care. 👉 Read more about this exciting development here: https://lnkd.in/g_fMvV_X #MedTech #TransplantMedicine #HealthcareInnovation #BiotechNews #PatientCare

    Paragonix to launch pancreas transplant transport system

    Paragonix to launch pancreas transplant transport system

    fiercebiotech.com

  • View organization page for Viltis, graphic

    4,697 followers

    🚀 Exciting advancements in clinical trials! A new study from Mass General Brigham shows that generative AI can significantly accelerate clinical trial enrollment for just pennies per patient. By using AI to screen electronic medical records, the accuracy and efficiency of patient identification are greatly enhanced, reducing time and costs. However, careful monitoring is essential to mitigate potential biases. This innovation holds promise for improving trial workflows and patient outcomes. Read more about this breakthrough here: https://lnkd.in/gfD3gha6 #Biotech #AI #ClinicalTrials #HealthcareInnovation #MedicalResearch

    Study shows generative AI can speed up clinical trial enrollment for pennies per patient

    Study shows generative AI can speed up clinical trial enrollment for pennies per patient

    fiercebiotech.com

  • View organization page for Viltis, graphic

    4,697 followers

    Happy 4th of July! Today, we celebrate the spirit of freedom, unity, and resilience that defines our great nation. As we gather with family and friends, let's take a moment to reflect on the values that bind us together and the sacrifices made by countless individuals to protect our liberties. On this special day, let's also celebrate the diversity that makes our country so vibrant and strong. Whether you're enjoying a backyard BBQ, watching fireworks light up the sky, or simply spending time with loved ones, may your day be filled with joy, laughter, and gratitude. Here's to the land of the free and the home of the brave. Happy Independence Day, everyone! 🎆✨ #FourthOfJuly #IndependenceDay #Unity #Freedom #Celebration #Gratitude

    • No alternative text description for this image
  • View organization page for Viltis, graphic

    4,697 followers

    📢 Dexcom's Strategic Shift: Transforming Challenges into Opportunities Dexcom is laying off 535 employees in San Diego as it shifts manufacturing to Mesa, Arizona, and transforms its headquarters into an innovation hub. This strategic move reflects Dexcom's rapid growth and focus on enhancing its R&D capabilities. Despite the layoffs, the company plans to add 400 new positions in San Diego and expand its global footprint, including a new European site in Ireland. Dexcom's continuous glucose monitors continue to lead in the market, underscoring its commitment to innovation in diabetes management. 🔗 https://lnkd.in/gZJV6t_J #MedTech #Biotech #Innovation #DiabetesManagement #Dexcom #Manufacturing #JobOpportunities #R&D

    Growing pains: Dexcom’s manufacturing move to lay off 535 in San Diego

    Growing pains: Dexcom’s manufacturing move to lay off 535 in San Diego

    fiercebiotech.com

  • View organization page for Viltis, graphic

    4,697 followers

    🌟 AI Transforming Drug Discovery: Market to Hit $11.93 Billion by 2033!🌟 Exciting times ahead for the biotech industry! A recent report highlights that the AI in drug discovery market is poised to expand to a staggering $11.93 billion by 2033. 🚀 The integration of AI is revolutionizing how we approach drug discovery and development, leading to significant advancements in efficiency and precision. Key benefits include: - Accelerated Drug Development: AI algorithms can analyze vast datasets swiftly, identifying potential drug candidates faster than ever. - Cost Efficiency: AI reduces the high costs associated with traditional drug discovery methods, making research more affordable. - Improved Accuracy: Enhanced predictive models lead to higher success rates in identifying viable drug compounds. As we embrace these innovations, it's crucial to stay updated and leverage AI to its fullest potential in our projects. The future of medicine is here, and it's powered by AI! 💡🔬 Read the full article for more insights: https://lnkd.in/gSFBFUJx #AI #DrugDiscovery #Biotech #Innovation #FutureOfMedicine #HealthcareTech

    AI In Drug Discovery Market Size to Expand US$ 11.93 Bn by 2033 | BioSpace

    biospace.com

  • View organization page for Viltis, graphic

    4,697 followers

    📢 Industry Update: BioMarin's Strategic Shift 📢 BioMarin Pharmaceutical has announced a significant restructuring, shedding 170 jobs as part of a strategic refocus on their research and development (R&D) efforts. This move comes as the company narrows its R&D scope to prioritize high-impact projects that align with their core strengths. 🔍 What's Changing? - Job Reductions: 170 positions are being eliminated, primarily in the R&D department. - Strategic Focus: BioMarin aims to streamline operations and concentrate on key therapeutic areas to enhance innovation and efficiency. 💡 Why It Matters: This restructuring reflects the evolving landscape of the biotech industry, where companies must continuously adapt to maintain a competitive edge. By reallocating resources to the most promising projects, BioMarin is positioning itself for long-term success and sustainable growth. 📈 Looking Ahead: While job cuts are always challenging, this realignment is expected to drive more focused and impactful research efforts. It’s a reminder of the dynamic nature of biotech, where strategic decisions are crucial for staying ahead in the race to develop groundbreaking therapies. Best of luck to those affected by these changes. The biotech community is resilient, and new opportunities will arise. https://lnkd.in/gKnMNT6U #Biotech #BioMarin #R&D #Innovation #StrategicShift #Biopharma #IndustryNews

    BioMarin sheds 170 jobs in wake of narrowed R&D refocus

    BioMarin sheds 170 jobs in wake of narrowed R&D refocus

    fiercebiotech.com

  • View organization page for Viltis, graphic

    4,697 followers

    🚀 Revolutionizing Clinical Trials with Generative AI! 🚀 A new study by Mass General Brigham highlights the potential of generative AI, like ChatGPT, in expediting clinical trial enrollment. By swiftly analyzing electronic medical records, the AI achieved up to 100% accuracy at just 11 cents per patient, drastically reducing costs and improving efficiency. While promising, the study underscores the importance of safeguards to prevent biases and ensure accurate results. This innovation could transform how we conduct clinical trials, enhancing both speed and cost-effectiveness. 🔗 https://lnkd.in/gfD3gha6 #AI #ClinicalTrials #HealthcareInnovation #GenerativeAI #MedicalResearch

    Study shows generative AI can speed up clinical trial enrollment for pennies per patient

    Study shows generative AI can speed up clinical trial enrollment for pennies per patient

    fiercebiotech.com

  • View organization page for Viltis, graphic

    4,697 followers

    📢 Exciting Growth in the Pharmacovigilance Market! The pharmacovigilance market is experiencing rapid expansion, projected to reach $12.48 billion by 2027. This growth is driven by increasing awareness of adverse drug reactions (ADRs), rising demand for safer medications, and the growing trend of outsourcing pharmacovigilance services to contract research organizations (CROs) and business process outsourcing (BPO) companies. 🌍💊 Key factors contributing to this surge include: - Increased ADR Incidents: Heightened post-market monitoring and strict regulatory guidelines are propelling the need for effective pharmacovigilance. - Outsourcing Trends: Pharmaceutical companies are increasingly outsourcing to improve cost efficiency and operational effectiveness. - Technological Advancements: Innovative pharmacovigilance software and tools are enhancing drug safety monitoring. With significant contributions from North America and the Asia Pacific, the market is set for a robust future. This growth is not just about compliance but also about ensuring patient safety and improving drug development processes. For more insights, read the full article on BioSpace. 🌐🔍 #Pharmacovigilance #Healthcare #Pharmaceuticals #DrugSafety #MarketGrowth #Outsourcing #Innovation #PatientSafety References: - https://lnkd.in/gBzu-frb

    Pharmacovigilance Market Experiencing Rapid Growth | BioSpace

    biospace.com

  • Viltis reposted this

    View organization page for The FDA Group, graphic

    8,570 followers

    With RA/QA teams feeling the pressure to get more done with fewer resources, staff augmentation (full-time consultant/contractor resourcing) has become a popular alternative to FTEs for projects or roles that require full-time work but don't justify a permanent hire. If you're wondering if anything in your upcoming project schedule lends itself to staff aug rather than tying up internal resources and hiring budget, here are just a few of the types of projects we've deployed full-time contracts specialists to execute on time and on budget: ▪ QMS Implementation and Remediation: Full-time consultants quickly assess the current system, develop a remediation plan, and train staff, ensuring compliance without long-term hiring delays. We find that staff aug provides specialized temporary expertise and accelerates project completion. ▪ Supplier Quality Management: Our bench of supplier quality engineers routinely conducts audits, implements quality agreements, and monitors ongoing performance, providing flexibility and scalability as the supply chain grows. Staff aug offers specialized skills without a permanent commitment for these projects which typically take a few weeks or months. ▪ Process Validation and Improvement: We commonly deploy process validation experts to conduct validation studies, implement improvements, and train staff, ensuring high standards without disrupting ongoing operations. Augmenting rather than devoting internal staff helps maintain production efficiency and quality. ▪ Computer System Validation (CSV): CSV is perfectly situated for staff aug. A specialized consultant develops validation plans, performs risk assessments, and ensures systems meet all regulatory requirements, providing the necessary expertise to handle complex validation tasks quickly and effectively. ▪ Quality Documentation and SOP Development: This is another area where objectivity and specialized expertise are key. Our documentation specialists draft, review, and revise SOPs, ensuring all documents comply with regulatory guidelines and improve operational efficiency. Staff aug provides specialized knowledge and much faster turnaround times. ▪ Complaint Handling and Adverse Event Reporting: Complaint handling specialists establish procedures, investigate complaints, and prepare regulatory reports, ensuring compliance and customer satisfaction. This allows for expert handling of sensitive issues without permanent staffing increases. ▪ Post-Market Surveillance: Our PMS experts design surveillance plans, collect and analyze data, and prepare regulatory reports, ensuring continuous monitoring and compliance. ▪ Backlog Reduction in Quality Management: Full-time consultants are brought in to tackle the backlog efficiently, ensuring critical tasks are completed promptly without overwhelming the permanent staff. This approach allows the company to maintain compliance and operational flow while addressing overdue tasks. #staffaugmentation

    • No alternative text description for this image
  • View organization page for Viltis, graphic

    4,697 followers

    🚀 Exciting News in AI Development! 🌟 The FDA has joined forces with Health Canada and the UK’s MHRA to push for greater transparency in AI-powered medical device development. This collaboration aims to ensure safety, efficacy, and trust in AI applications in healthcare. Key highlights: - Emphasis on transparency for health professionals, patients, and regulators. - Importance of clear communication on AI products' use, performance, and internal logic. - Commitment to human-centered design and risk management. Read more about this international initiative here: https://lnkd.in/eZRu-AHU #AI #Healthcare #Innovation #Regulation #Transparency

    FDA joins international push for transparency in AI development

    FDA joins international push for transparency in AI development

    fiercebiotech.com

Similar pages

Browse jobs